ARCHIVES

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

March 29, 2013

Cancer Researchers Ask Congress for Full Bypass Budge Funding

April 27, 1990

NCI Moves Ahead With Trials Database, Reporting Studies In Progress At Cancer Centers

July 15, 2011

NIH reauthorization to be topic of July 19 hearing.

July 15, 2005

1985 International Cancer Congress to Be In Budapest

September 24, 1982

Bailes: ASCO To Strengthen State Affiliates, Begin Quality Of Care Study, Talk With FDA.

May 26, 2000